Candidate vaccine against MERS passes first test

September 6, 2013
Candidate vaccine passes first test

In collaboration with colleagues in Rotterdam, an LMU research team led by Professor Gerd Sutter has produced the first candidate vaccine against the MERS virus, a novel and highly pathogenic coronavirus.

Last autumn, were alarmed by reports of the isolation of a previously unknown and highly virulent coronavirus from humans. The strain causes an acute respiratory syndrome and induces severe, and often fatal, lung damage. All 108 confirmed infections, including those identified in Germany and other parts of Europe, involved patients from the Arabian Peninsula and the Middle East. Hence, the responsible has been named "Middle East Respiratory Syndrome Coronavirus (MERS-CoV)". The virus is thought to have merged from an animal reservoir, but its primary source has yet to be discovered. Nevertheless, it is clear that MERS-CoV has acquired the capacity for person-to-person transmission, as relatives of the victims, as well as some hospital personnel, have been infected by direct contact with patients.

During the past several months, a team led by Professor Gerd Sutter at LMU's Institute for Infectious Diseases and Zoonoses, in collaboration with colleagues at the Erasmus Medical Center in Rotterdam and at Marburg University, has created a vaccine against the MERS virus, which they describe in the Journal of Virology. "The we have developed is the first one directed against the MERS coronavirus that could be administered to humans, as an emergency measure, in the event of an epidemic," says Sutter.

Developed in less than a year

The starting point for the new vaccine was a related virus known as Modified Vaccinia virus Ankara (MVA). MVA is an attenuated strain of the virus that causes , and has been used for more than 30 years for the manufacture of . Indeed, MVA is at the heart of a worldwide effort to design and generate vaccines not only against but also against cancers. In this context, MVA serves as the carrier for specific antigens that elicit the production of protective antibodies in the immunized host. MERS-CoV is known to bind to human cells via its so-called spike (S) protein, which is exposed on the surface of its membrane envelope. Sutter and his team therefore used molecular biological methods to introduce the gene for the MERS S protein into the MVA genome.

Following injection into mice, the resulting MVA-MERS-S virus particles were found to induce the production of antibodies that specifically recognized MERS-CoV and effectively blocked infection of susceptible cells in tissue culture. In order to confirm that vaccination with MVA-MERS-S also prevents the potentially lethal lung damage associated with MERS infections in humans, a suitable test system must be developed. So far, no animal hosts are known to display symptoms of comparable severity to those seen in humans upon exposure to MERS-CoV.

"We have produced the best vaccine possible given the present state of our knowledge," says Gerd Sutter. "This demonstrates that, using our method, we can fabricate a candidate vaccine within less than a year. MVA-MERS-S could be used as it stands for the production of a vaccine." So if the coronavirus were to give rise to a full-fledged epidemic, the vaccine could be made available rapidly. – And the same method can be used to construct immunogenic particles that induce protective immunity against other viral pathogens, enabling the production of candidate vaccines within a similarly short period of time.

Explore further: Saudi man dies of MERS virus: ministry

More information: jvi.asm.org/content/early/2013 … VI.01672-13.abstract

Related Stories

Saudi man dies of MERS virus: ministry

August 25, 2013
A Saudi man has died of the coronavirus MERS, bringing the kingdom's death toll from the SARS-like virus to 41, while two new cases were registered, the government said Sunday.

Two deaths, six new MERS virus cases in Saudi: WHO

August 28, 2013
Eight new cases of the deadly coronavirus MERS, a SARS-like infection, have been registered in Saudi Arabia, the World Health Organisation said on Wednesday.

Saudi man dies of MERS virus: ministry

July 28, 2013
A Saudi man has died of the coronavirus MERS and another has contracted the virus, the health ministry said on Saturday, bringing the kingdom's deaths from the virus to 39.

Saudi man dies of MERS virus

August 28, 2013
A Saudi man has died of the coronavirus MERS, bringing the kingdom's death toll from the SARS-like virus to 42, health authorities said Wednesday, adding a new case was registered.

Signs of MERS coronavirus found in dromedary camels

August 8, 2013
Researchers searching for signs of Middle East respiratory syndrome coronavirus (MERS-CoV) in livestock animals have found antibodies specific to the new virus in dromedary camels. The research, published in The Lancet Infectious ...

Does the dangerous new Middle East coronavirus have an African origin?

July 24, 2013
The MERS-coronavirus is regarded as a dangerous novel pathogen: Almost 50 people have died from infection with the virus since it was first discovered in 2012. To date all cases are connected with the Arabian peninsula. Scientists ...

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.